Education
About Us
Working with TipRanks
Follow Us
Apogee Therapeutics, Inc. (APGE)
NASDAQ:APGE
APGE Analyst Ratings
Strong Buy
11 Buy
2 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
APGE Stock 12 Month Forecast
Average Price Target
$106.00
▲(47.43% Upside)
| Highest Price Target$137.00 | Average Price Target$106.00 | Lowest Price Target$82.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
BTIG
$137
Buy
90.54%
Upside
Reiterated
03/16/26
Wedbush
$71.9→$95
Buy
32.13%
Upside
Reiterated
03/15/26
Guggenheim
$130
Buy
80.81%
Upside
Reiterated
03/11/26
TD Cowen
―
Buy
―
Reiterated
03/10/26
Citi
$95
Buy
32.13%
Upside
Reiterated
03/05/26
Canaccord Genuity
$89
Buy
23.78%
Upside
Reiterated
03/04/26
Mizuho Securities
$105
Buy
46.04%
Upside
Reiterated
03/03/26
Stifel Nicolaus
$133
Buy
84.98%
Upside
Reiterated
03/02/26
RBC Capital
$83→$82
Hold
14.05%
Upside
Reiterated
03/02/26
Craig-Hallum
$116
Buy
61.34%
Upside
Reiterated
03/02/26
UBS
$100
Buy
39.08%
Upside
Reiterated
03/02/26
Bank of America Securities
$84
Buy
16.83%
Upside
Reiterated
01/27/26
Wolfe Research
―
Hold
―
Initiated
01/07/26
Stephens
$95
Buy
32.13%
Upside
Initiated
12/17/25
Analyst Type
Any
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
BTIG
$137
Buy
90.54%
Upside
Reiterated
03/16/26
Wedbush
$71.9→$95
Buy
32.13%
Upside
Reiterated
03/15/26
Guggenheim
$130
Buy
80.81%
Upside
Reiterated
03/11/26
TD Cowen
―
Buy
―
Reiterated
03/10/26
Citi
$95
Buy
32.13%
Upside
Reiterated
03/05/26
Canaccord Genuity
$89
Buy
23.78%
Upside
Reiterated
03/04/26
Mizuho Securities
$105
Buy
46.04%
Upside
Reiterated
03/03/26
Stifel Nicolaus
$133
Buy
84.98%
Upside
Reiterated
03/02/26
RBC Capital
$83→$82
Hold
14.05%
Upside
Reiterated
03/02/26
Craig-Hallum
$116
Buy
61.34%
Upside
Reiterated
03/02/26
UBS
$100
Buy
39.08%
Upside
Reiterated
03/02/26
Bank of America Securities
$84
Buy
16.83%
Upside
Reiterated
01/27/26
Wolfe Research
―
Hold
―
Initiated
01/07/26
Stephens
$95
Buy
32.13%
Upside
Initiated
12/17/25
Best Analysts Covering Apogee Therapeutics
3 Months
xxx
Success Rate
6/9 ratings generated profit
Average Return
+17.96%
a xxx
rating ―
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 66.67% of your transactions generating a profit, with an average return of +17.96% per trade.
1 Year
Success Rate
8/9 ratings generated profit
Average Return
+52.90%
a rating ―
Copying Geoff Meacham's trades and holding each position for 1 Year would result in 88.89% of your transactions generating a profit, with an average return of +52.90% per trade.
2 Years
xxx
Success Rate
10/11 ratings generated profit
Average Return
+67.60%
a xxx
rating ―
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 90.91% of your transactions generating a profit, with an average return of +67.60% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
APGE Analyst Recommendation Trends
Rating
Nov 25
Dec 25
Jan 26
Feb 26
Mar 26
Strong Buy
11
11
10
7
12
Buy
6
10
21
17
18
Hold
0
0
2
2
3
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
17
21
33
26
33
Each month's total comprises the sum of three months' worth of ratings.
APGE Financial Forecast
APGE Stock Forecast FAQ
What is APGE’s average 12-month price target, according to analysts?
Based on analyst ratings, Apogee Therapeutics, Inc.’s 12-month average price target is 106.00.
What is APGE’s upside potential, based on the analysts’ average price target?
Apogee Therapeutics, Inc. has 47.43% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is APGE a Buy, Sell or Hold?
Apogee Therapeutics, Inc. has a consensus rating of Strong Buy which is based on 11 buy ratings, 2 hold ratings and 0 sell ratings.
What is Apogee Therapeutics, Inc.’s price target?
The average price target for Apogee Therapeutics, Inc. is 106.00. This is based on 13 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $137.00 ,the lowest forecast is $82.00. The average price target represents 47.43% Increase from the current price of $71.9.
The highest analyst price target is $137.00 ,the lowest forecast is $82.00. The average price target represents 47.43% Increase from the current price of $71.9.
What do analysts say about Apogee Therapeutics, Inc.?
Apogee Therapeutics, Inc.’s analyst rating consensus is a Strong Buy. This is based on the ratings of 13 Wall Streets Analysts.
How can I buy shares of APGE?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.